SeaStar Medical (NASDAQ:ICU – Get Free Report) and Bausch + Lomb (NYSE:BLCO – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, profitability and institutional ownership.
Earnings and Valuation
This table compares SeaStar Medical and Bausch + Lomb”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| SeaStar Medical | $140,000.00 | 153.45 | -$24.83 million | ($2.62) | -0.24 |
| Bausch + Lomb | $4.79 billion | 1.16 | -$317.00 million | ($0.78) | -20.08 |
Risk and Volatility
SeaStar Medical has a beta of -1.07, indicating that its stock price is 207% less volatile than the S&P 500. Comparatively, Bausch + Lomb has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500.
Analyst Recommendations
This is a summary of current recommendations for SeaStar Medical and Bausch + Lomb, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SeaStar Medical | 1 | 0 | 0 | 0 | 1.00 |
| Bausch + Lomb | 2 | 8 | 3 | 0 | 2.08 |
Bausch + Lomb has a consensus price target of $15.70, indicating a potential upside of 0.26%. Given Bausch + Lomb’s stronger consensus rating and higher possible upside, analysts plainly believe Bausch + Lomb is more favorable than SeaStar Medical.
Insider and Institutional Ownership
1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 11.1% of Bausch + Lomb shares are held by institutional investors. 1.3% of SeaStar Medical shares are held by company insiders. Comparatively, 0.2% of Bausch + Lomb shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Profitability
This table compares SeaStar Medical and Bausch + Lomb’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SeaStar Medical | -1,915.27% | N/A | -232.65% |
| Bausch + Lomb | -5.58% | 2.33% | 1.12% |
Summary
Bausch + Lomb beats SeaStar Medical on 10 of the 14 factors compared between the two stocks.
About SeaStar Medical
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
About Bausch + Lomb
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.
Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with MarketBeat.com's FREE daily email newsletter.
